Recipharm Expands Blow-Fill-Seal Capacity at France Facility

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016, Volume 11, Issue 8

The company will invest €18 million in its Kaysersberg facility to expand blow-fill-seal capacity.

On July 5, 2016, Recipharm announced that the company will invest €18 million (approximately $19.73) to expand blow-fill-seal (BFS) capacity at its site in Kaysersberg, France. The investment will include the introduction of a BFS high-speed filling and packaging line, Recipharm said in a press announcement. Recihparm’s Kaysersberg site is a sterile facility specializing in BFS technology for sterile liquids.

Recipharm says it will also prepare to add three additional filling lines to the facility in upcoming years, increasing the company’s BFS capacity by 50%. Yves Buelens, general manager of the Kaysersberg site, said the company is experiencing increased demand for BFS services. “We are experiencing increased demand for our blow-fill-seal services from markets including the United States, Turkey, Australia, and Canada, and the new filling line will help us to meet this growing need,” Buelens noted in a press announcement.

Source: Recipharm